Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4711
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sinopharm Group Co Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sinopharm Group Co Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sinopharm Group Co. Limited (Sinopharm or ‘the group’) is a distributor of healthcare products in China. It provides products such as pharmaceutical products, medical equipments, chemical reagents and laboratory supplies. Sinopharm provides supply chain solutions, logistics and distribution and other value-added services to domesticandforeignmanufacturer and suppliers of pharmaceutical products, medical equipment and supplies and other healthcare products. The group also offers health consultation, medical consulting, market information consulting and investigation, convention and exhibition services. It caters hospitals, other distributors, retail drug stores and primary health services institutions. The company is headquartered in Changning District, Shanghai, China.

Scope

- Detailed information on Sinopharm Group Co Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sinopharm Group Co Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sinopharm Group Co Limited including a breakdown and examination of key business segments
- Intelligence on Sinopharm Group Co Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sinopharm Group Co Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sinopharm Group Co Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sinopharm Group Co Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sinopharm Group Co Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Sinopharm Group Co Limited: Company Overview
Sinopharm Group Co Limited: Overview and Key Facts
Sinopharm Group Co Limited: Overview
Sinopharm Group Co Limited: Key Facts
Sinopharm Group Co Limited: Key Employees
Sinopharm Group Co Limited: Key Employee Biographies
Sinopharm Group Co Limited: Major Products and Services
Sinopharm Group Co Limited: Company History
Sinopharm Group Co Limited: Management Statement
Sinopharm Group Co Limited: Locations and Subsidiaries
Sinopharm Group Co Limited: Key Competitors
Sinopharm Group Co Limited: Company Analysis
Sinopharm Group Co Limited: Business Description
Sinopharm Group Co Limited: SWOT Analysis
Sinopharm Group Co Limited: SWOT Overview
Sinopharm Group Co Limited: Strengths
Sinopharm Group Co Limited: Weaknesses
Sinopharm Group Co Limited: Opportunities
Sinopharm Group Co Limited: Threats
Sinopharm Group Co Limited: Corporate Financial Deals Activity
Sinopharm Group Co Limited: Financial Deals Overview
Sinopharm Group Co Limited: Targets and Partners
Sinopharm Group Co Limited: Top Deals 2016 – 2020YTD*
Sinopharm Group Co Limited: Advisors
Sinopharm Group Co Limited: Top Financial Advisors
Sinopharm Group Co Limited: Mergers and Acquisitions
Sinopharm Group Co Limited: Corporate Venturing
Sinopharm Group Co Limited: Capital Raising
Sinopharm Group Co Limited: Partnership
Sinopharm Group Co Limited: Recent Developments
Sinopharm Group Co Limited: News and Events Summary
Sinopharm Group Co Limited: Business Expansion
Sinopharm Group Co Limited: Contracts
Sinopharm Group Co Limited: Corporate Governance
Sinopharm Group Co Limited: Financial Deals
Sinopharm Group Co Limited: Financial Performance
Sinopharm Group Co Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Sinopharm Group Co Limited: Key Facts
Table 2: Sinopharm Group Co Limited: Key Employees
Table 3: Sinopharm Group Co Limited: Company History
Table 4: Sinopharm Group Co Limited: Locations and Subsidiaries
Table 5: Sinopharm Group Co Limited: Key Competitors
Table 6: Sinopharm Group Co Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sinopharm Group Co Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Sinopharm Group Co Limited: M&A Average Deal Size - Value (US$m)
Table 9: Sinopharm Group Co Limited: Targets and Partners
Table 10: Sinopharm Group Co Limited: Top Deals 2016 - 2020YTD*
Table 11: Sinopharm Group Co Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Sinopharm Group Co Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Sinopharm Group Co Limited: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Sinopharm Group Co Limited: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 15: Sinopharm Group Co Limited: Corporate Venturing by Geography (2016 - YTD*2020)
Table 16: Sinopharm Group Co Limited: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Sinopharm Group Co Limited: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Sinopharm Group Co Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Sinopharm Group Co Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Sinopharm Group Co Limited: News and Events Summary
Table 21: Sinopharm Group Co Limited: Business Expansion
Table 22: Sinopharm Group Co Limited: Contracts
Table 23: Sinopharm Group Co Limited: Corporate Governance
Table 24: Sinopharm Group Co Limited: Financial Deals
Table 25: Sinopharm Group Co Limited: Financial Performance
Table 26: Sinopharm Group Co Limited: Strategy and Operations

★海外企業調査レポート[Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IBC Solar AG:電力:M&Aディール及び事業提携情報
    Summary IBC Solar AG (IBC Solar), formerly IBC Solartechnik, is a solar energy company that provides photovoltaic and energy storage solutions and services. The company’s product range includes solar parks, self-consumption systems for commercial enterprises and private households, diesel hybrid sol …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Faron Pharmaceuticals Oy (FARN):企業の財務・戦略的SWOT分析
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 …
  • Hess Corp (HES):石油・ガス:M&Aディール及び事業提携情報
    Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Malaysia/Thailand (JDA), and Malaysia. It offers fee-based services including gathering, …
  • JTEKT Corp (6473):企業の財務・戦略的SWOT分析
    JTEKT Corp (6473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • La Jolla Pharmaceutical Company (LJPC):製薬・医療:M&Aディール及び事業提携情報
    Summary La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for life threatening diseases. The company’s major product includes Giapreza, an injection for intravenous infusion indicated to increase blood pressu …
  • Barrick Gold Corp:企業の戦略・SWOT・財務情報
    Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • Rambus Inc.:企業のM&A・事業提携・投資動向
    Rambus Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rambus Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Serodus ASA:製薬・医療:M&Aディール及び事業提携情報
    Summary Serodus ASA (Serodus) is a drug development company that develops treatments for unmet clinical needs in the areas of diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephropathy; SER130AMI, an …
  • Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報
    Summary Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostat …
  • PPL Corporation (PPL):電力:M&Aディール及び事業提携情報
    Summary PPL Corporation (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and …
  • Republic National Distributing Company:戦略・SWOT・企業財務分析
    Republic National Distributing Company - Strategy, SWOT and Corporate Finance Report Summary Republic National Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Alon USA Energy Inc (ALJ)-石油・ガス分野:企業M&A・提携分析
    Summary Alon USA Energy Inc (Alon USA), a subsdiary of Delek US Holdings, Inc., is a refiner and marketer of petroleum products. The products offered by the company include various grades of gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based …
  • Ping An Insurance (Group) Company of China Ltd (601318):企業の財務・戦略的SWOT分析
    Ping An Insurance (Group) Company of China Ltd (601318) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Motus Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motus Therapeutics Inc (Motus), formerly Rhythm Pharmaceuticals, Inc. is a subsidiary of Rhythm Holding Company LLC, biotechnology company that provides therapies. The company develops peptide therapeutics for the treatment of metabolic diseases. Its products under clinical development inclu …
  • Siemens Gamesa Renewable Energy SA (SGRE):企業の財務・戦略的SWOT分析
    Siemens Gamesa Renewable Energy SA (SGRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務分析
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Iconix Brand Group, Inc.:企業のM&A・事業提携・投資動向
    Iconix Brand Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iconix Brand Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • LHC Group Inc (LHCG):企業の財務・戦略的SWOT分析
    Summary LHC Group Inc (LHC Group) is an in-home healthcare service provider. The center offers home health, hospice, personal care services and facility-based services. It covers a range of healthcare needs for patients and families dealing with illness, injury, and chronic conditions. LHC Group pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆